Sunday, April 20, 2025
Home 2024 January

Monthly Archives: January 2024

2024 Watch List

Adding GeoVax (GOVX) $3.32 to Reverse Stock Split Watch List.

Editor / Curator -
All News

Corbus Pharma (CRBP) Explodes Higher After Reverse Split, up 1,288%!

Editor / Curator -
All News

Zivo Bioscience (ZIVO) Screams 2,608% Higher AFTER Reverse Split!

Editor / Curator -
All News

Top 10 AI Titans.

Editor / Curator -
All News

Research Report: Society Pass (SOPA) $0.22. Price Target $4.00.

Editor / Curator -
Biotech News

ATCC Announces $87 Million Award for Project NextGen for Vaccines, from...

Editor / Curator -
2024 Watch List

Ardelyx (ARDX), Raymond James up Price Target, Citigroup Joins the Party.

Editor / Curator -
2024 Watch List

Is David Dodd on to his Next Billion Dollar Payday for...

Editor / Curator -
All News

Happy New Year! Year End Charts.

Editor / Curator -
2020 Watch List

Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results...

Editor / Curator -

Latest article

Epidemic Denial: RFK Jr. Holds Press Conference on new Autism findings from the CDC

All News Editor / Curator -
Health and Human Services Secretary Robert F. Kennedy Jr. will be joined by officials on Wednesday to discuss the latest Autism and...

GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

2025 Watch List Editor / Curator -
Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

Adding Allarity (ALLR) $0.70, to Watch List.

2025 Watch List Editor / Curator -
LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.